Staff Profile | Faculty of Medical Sciences

Dr John Mansfield

Senior Lecturer/Consultant

Email: j.c.mansfield@ncl.ac.uk
Telephone: +44 (0) 191 282 0135
Address: RVI

Publications

Lamb CA, Price M, Robinson M, Gunn MC, Thompson NP, Mansfield JC. A real life retrospective analysis of drug expenditure reveals no significant cost difference between infliximab and adalimumab in the treatment of Adult Crohn's Disease. In: Annual Meeting of the British Society of Gastroenterology. 2011, Birmingham, England: Gut: BMJ Publishing Group.
Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagace C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RSN, Floyd JAB, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panes J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics 2011, 43(3), 246-252.
Lamb CA, Price M, Jones DE, Mansfield JC. Patients with Crohn's Disease report high levels of fatigue during a symptomatic disease flare. In: Gut: Annual Meeting of the British Society of Gastroenterology. 2011, Birmingham, UK: BMJ Group.
Prescott NJ, Lehne B, Harrison K, Knight J, Weale M, Simpson M, Green P, Lewis C, Hart A, Sanderson J, Mansfield J, Schlitt T, Mathew C. Screening for rare pathogenic sequence variants in inflammatory bowel disease. In: Gut: Annual Meeting of the British Society of Gastroenterology. 2011, Birmingham, UK: BMJ Group.
Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S, Vukcevic D, Barnes C, Conrad DF, Giannoulatou E, Holmes C, Marchini JL, Stirrups K, Tobin MD, Wain LV, Yau C, Aerts J, Ahmad T, Andrews TD, Arbury H, Attwood A, Auton A, Ball SG, Balmforth AJ, Barrett JC, Barroso I, Barton A, Bennett AJ, Bhaskar S, Blaszczyk K, Bowes J, Brand OJ, Braund PS, Bredin F, Breen G, Brown MJ, Bruce IN, Bull J, Burren OS, Burton J, Byrnes J, Caesar S, Clee CM, Coffey AJ, Connell JMC, Cooper JD, Dominiczak AF, Downes K, Drummond HE, Dudakia D, Dunham A, Ebbs B, Eccles D, Edkins S, Edwards C, Elliot A, Emery P, Evans DM, Evans G, Eyre S, Farmer A, Ferrier IN, Feuk L, Fitzgerald T, Flynn E, Forbes A, Forty L, Franklyn JA, Freathy RM, Gibbs P, Gilbert P, Gokumen O, Gordon-Smith K, Gray E, Green E, Groves CJ, Grozeva D, Gwilliam R, Hall A, Hammond N, Hardy M, Harrison P, Hassanali N, Hebaishi H, Hines S, Hinks A, Hitman GA, Hocking L, Howard E, Howard P, Howson JMM, Hughes D, Hunt S, Isaacs JD, Jain M, Jewell DP, Johnson T, Jolley JD, Jones IR, Jones LA, Kirov G, Langford CF, Lango-Allen H, Lathrop GM, Lee J, Lee KL, Lees C, Lewis K, Lindgren CM, Maisuria-Armer M, Maller J, Mansfield J, Martin P, Massey DCO, McArdle WL, McGuffin P, McLay KE, Mentzer A, Mimmack ML, Morgan AE, Morris AP, Mowat C, Myers S, Newman W, Nimmo ER, O'Donovan MC, Onipinla A, Onyiah I, Ovington NR, Owen MJ, Palin K, Parnell K, Pernet D, Perry JRB, Phillips A, Pinto D, Prescott NJ, Prokopenko I, Quail MA, Rafelt S, Rayner NW, Redon R, Reid DM, Renwick A, Ring SM, Robertson N, Russell E, St Clair D, Sambrook JG, Sanderson JD, Schuilenburg H, Scott CE, Scott R, Seal S, Shaw-Hawkins S, Shields BM, Simmonds MJ, Smyth DJ, Somaskantharajah E, Spanova K, Steer S, Stephens J, Stevens HE, Stone MA, Su Z, Symmons DPM, Thompson JR, Thomson W, Travers ME, Turnbull C, Valsesia A, Walker M, Walker NM, Wallace C, Warren-Perry M, Watkins NA, Webster J, Weedon MN, Wilson AG, Woodburn M, Wordsworth BP, Young AH, Zeggini E, Carter NP, Frayling TM, Lee C, McVean G, Munroe PB, Palotie A, Sawcer SJ, Scherer SW, Strachan DP, Tyler-Smith C, Brown MA, Burton PR, Caulfield MJ, Compston A, Farrall M, Gough SCL, Hall AS, Hattersley AT, Hill AVS, Mathew CG, Pembrey M, Satsangi J, Stratton MR, Worthington J, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Parkes M, Rahman N, Todd JA, Samani NJ, Donnelly P. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010, 464(7289), 713-720.
Dipper CR, Maitra S, Thomas R, Lamb CA, McLean-Tooke APC, Ward R, Smith D, Spickett G, Mansfield JC. Anti-tissue transglutaminase antibodies in the follow-up of adult coeliac disease. Alimentary Pharmacology and Therapeutics 2009, 30(3), 236-244.
Lamb CA, Mohiuddin MK, Gicquel J, Neely D, Bergin FG, Hanson JM, Mansfield JC. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. British Journal of Surgery 2009, 96(6), 663-674.
Mckenna M, Mansfield JC. Safety of bisphosphonates in women of child bearing age. Alimentary Pharmacology and Therapeutics 2009, 29(11), 1214-1215.
Chapman JM, Onnie CM, Prescott NJ, Fisher SA, Mansfield JC, Mathew CG, Lewis CM, Verzilli CJ, Whittaker JC. Searching for Genotype-Phenotype Structure: Using Hierarchical Log-Linear Models in Crohn Disease. American Journal of Human Genetics 2009, 84(2), 178-187.
Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, Bagnall R, Mirza MM, Sanderson J, Forbes A, Mansfield JC, Lewis CM, Schreiber S, Mathew CG. A Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn's Disease and Is Independent of CARD15 and IBD5. Gastroenterology 2007, 132(5), 1665-1671.
Mansfield JC, Parkes M, Hawthorne AB, Forbes A, Probert CSJ, Perowne RC, Cooper A, Zeldis JB, Manning DC, Hawkey CJ. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. Alimentary Pharmacology and Therapeutics 2007, 26(3), 421-430.
Fisher SA, Mirza MM, Onnie CM, Soars D, Lewis CM, Prescott NJ, Mathew CG, Sanderson J, Forbes A, Todhunter C, Donaldson P, Mansfield J. Combined Evidence From Three Large British Association Studies Rejects TUCAN/CARD8 as an IBD Susceptibility Gene. Gastroenterology 2007, 132(5), 2078-2080.
Young AH, Ferrier IN, Ball SG, Mohiuddin MK, Todhunter CE, Mansfield JC, members of the Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145), 661-678.
Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ, Sanderson J, Bredin F, Berzuini C, Forbes A, Lewis CM, Cardon L, Deloukas P, Jewell D, Mathew CG, Parkes M, Satsangi J. IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease. Gastroenterology 2007, 132(5), 1657-1664.
Pearce AV, Fisher S, Prescott N, Onnie C, Pattni R, Green P, Forbes A, Mansfield J, Sanderson J, Schreiber S, Lewis CM, Mathew CG. Investigation of assocaiation of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population. International Journal of Colorectal Disease 2007, 22(4), 419-424.
Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, Cardon L, Mathew CG. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nature Genetics 2007, 39(7), 830-832.
Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, Sanderson J, Mansfield J, Annese V, Forbes A, Lewis CM, Schreiber S, Rioux JD, Mathew CG. Direct or indirect association in a complex disease: The role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Human Mutation 2006, 27(8), 778-785.
King K, Sheikh MF, Cuthbert AP, Fisher SA, Onnie CM, Mirza MM, Pattni RC, Sanderson J, Forbes A, Mansfield J, Lewis CM, Roberts RG, Mathew CG. Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Human Mutation 2006, 27(1), 44-54.
Shenderey RL, Thompson N, Mansfield JC, Rees C. Adenocarcinoma as a complication of small bowel Crohn's disease. European Journal of Gastroenterology & Hepatology 2005, 17(11), 1255-1257.
Daly MJ, Pearce AV, Farwell L, Fisher SA, Latiano A, Prescott NJ, Forbes A, Mansfield J, Sanderson J, Langelier D, Cohen A, Bitton A, Wild G, Lewis CM, Annese V, Mathew CG, Rioux JD. Association of DLG5 R30Q variant with inflammatory bowel disease. European Journal of Human Genetics 2005, 13(7), 835-839.
Balredin R, Barrett P, Wooff DA, Mansfield JC, Yiannakou Y. How Good is Zoom Endoscopy in Assessing Villous Atrophy in Coeliac Disease?. Endoscopy 2005, 37(10), 994-998.
Masson S, Nylander D, Mansfield JC. How important is onset of action in ulcerative colitis therapy?. Drugs 2005, 65(15), 2069-2083.
Todhunter CE, Sutherland-Craggs A, Bartram S, Donaldson PT, Daly AK, Francis RM, Mansfield JC, Thompson NP. Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease. Gut 2005, 54(11), 1579-1584.
Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Alimentary Pharmacology and Therapeutics 2005, 21(8), 921-931.
Crosbie J, Varma J, Mansfield J. Yersinia enterocolitica infection in a patient with hemachromatosis masquerading as proximal colon cancer with liver metastases: Report of a case. Diseases of the Colon and Rectum 2005, 48(2), 390-392.
Wayman J, Mansfield JC, Matthewson K, Richardson DL, Griffin SM. Combined percutaneous and endoscopic procedures for bile duct obstruction: Simultaneous and delayed techniques compared. Hepato-Gastroenterology 2003, 50(52), 915-918.
Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J, Mansfield J, Donaldson P, Macpherson AJS, Forbes A, Schreiber S, Lewis CM, Mathew CG. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. American Journal of Human Genetics 2003, 72(4), 1018-1022.
Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J, Mansfield J, Donaldson P, MacPherson A, Forbes A, Schreiber S, Lewis CM, Mathew CG. Genetic evidence for interaction of the 5Q31 cytokine locus and the CARD15 gene in Crohn's disease. In: Gut: Annual Meeting of the British Society of Gastroenterology. 2003, Birmingham, UK: BMJ Group.
Fisher SA, Moody A, Mirza MM, Cuthbert AP, Hampe J, Macpherson A, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. Genetic variation at the chromosome 16 chemokine gene cluster: Development of a strategy for association studies in complex disease. Annals of Human Genetics 2003, 67(5), 377-390.
King K, Moody A, Fisher SA, Mirza MM, Cuthbert AP, Hampe J, Sutherland-Craggs A, Sanderson J, MacPherson AJ, Forbes A, Mansfield JC, Schreiber S, Lewis CM, Mathew CG. Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel disease. International Journal of Immunogenetics 2003, 30(3), 187-190.
Gunn MC, Cavin AA, Mansfield JC. Management of irritable bowel syndrome. Postgraduate Medical Journal 2003, 79(929), 154-158.
Sutherland-Craggs A, Mansfield JC, Donaldson PT, Daly A, Francis RR, Thompson NP. Osteoporosis in Crohn's disease is not determined by vitamin D receptor and interleukin-6 genotype. In: Gut: Annual Meeting of the British Society of Gastroenterology. 2003, Birmingham, UK: BMJ Group.
Mansfield JC. Pentasa may not be the optimal 5ASA. Gut 2003, 52(5), 771.
Jaafar A, Hawkyard C, Lapworth K, Davidson B, Ledger J, Wilkins J, Mansfield J, Thompson NP. Screening for malnutrition: Impact of the malnutrition universal screening tool (MUST). In: Gut: Annual Meeting of the British Society of Gastroenterology. 2003, Birmingham, UK: BMJ Group.
King K, Onnie C, Mirza M, Fisher S, Cuthbert A, Sanderson S, Forbes A, Mansfield J, Lewis C, Mathew C. Sequence variation in the CARD15 (nod2) gene and susceptibility to Crohn's disease. In: Gut: Annual Meeting of the British Society of Gastroenterology. 2003, Birmingham, UK: BMJ Group.
Mansfield JC. Which 5-ASA?. Gut 2003, 52(5), 771.
Sutherland-Craggs A, Mansfield JC, Hudson M, Cuthbert A, Fisher S, Mathew C, Bartram S, Daly A, Francis R, Thompson NP. Osteoporosis in Crohn's disease is not determined by NOD2 genotype [abstract]. Gut 2002, 50(s2), A80 abstract no. 291.
Mansfield JC, Harrison-Diver V. Smoking cessation in Crohn's disease: Worthwhile results are possible [abstract]. Gut 2002, 50(s2), A75 abstract no. 273.
Green JRB, Mansfield JC, Gibson JA, Kerr GD, Thornton PC. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis. Alimentary Pharmacology and Therapeutics 2002, 16(1), 61-68.
Mansfield JC, Giaffer MH, Cann PA, McKenna D, Thornton PC, Holdsworth CD. A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis. Alimentary Pharmacology and Therapeutics 2002, 16(1), 69-77.
Mathew CG, Mirza M, Fisher S, King K, Hampe J, Sanderson J, Forbes A, Mansfield J, Cuthbert A, Schreiber S, Lewis CM. Contribution of genetic variants at CARD15 and the chromosome 5q31 locus to Crohn's disease. In: American Journal of Human Genetics: 52nd Annual Meeting of the American Society of Human Genetics. 2002, Baltimore, Maryland, USA: Cell Press.
Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJP, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122(4), 867-874.
Craggs A, West S, Curtis A, Welfare MR, Hudson M, Donaldson PT, Mansfield JC. Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and crohn disease in multiple populations from northeast England. Scandinavian Journal of Gastroenterology 2001, 36(11), 1173-1178.
Aithal GP, Mansfield JC. Review article: The risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Alimentary Pharmacology and Therapeutics 2001, 15(8), 1101-1108.
Aithal GP, Craggs A, Day CP, Welfare M, Daly AK, Mansfield JC, Hudson M. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease. Digestive Diseases and Sciences 2001, 46(7), 1520-1525.
Craggs A, Welfare M, Donaldson PT, Mansfield JC. The CC chemokine receptor 5 Delta 32 mutation is not associated with inflammatory bowel disease (IBD) in NE England. Genes and Immunity 2001, 2(2), 114-116.
Craggs A, West SP, Curtis A, Welfare M, Hudson M, Donaldson PT, Mansfield JC. Absence of a genetic association between IL-1RN and ulcerative colitis in multiple populations from NE England. In: GUT. 2000.
Bartram SA, Hainsworth PJ, Mansfield J, Peaston R, Francis RM, Walshaw D, Thompson NP. Bone mineral density & risk factors for osteoporosis in patients with Crohn's disease. In: GASTROENTEROLOGY. 2000.
King T, Firth M, Kelly T, Huey D, Mansfield J, Plusa S. Psychological factors which influence adjustment to inflammatory bowel disease. In: GUT. 2000.
Mansfield JC. Balsalazide - A viewpoint. DRUGS 1998, 56(1), 90-90.
A. J. Leonard, J. W. W. Killen, J. C. Mansfield, G. J. Gibson, M. Hudson and N. A. G. Jones. Difficulties in diagnosis and treatment of spinal tuberculosis. Hospital Medicine 1998, 59, 656-657.
Mansfield JC, Griffin SM, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut 1997, 40(5), 671-677.
Mansfield JC, Tanner AR, Bramble MG. Information for patients about inflammatory bowel disease. Journal of the Royal College of Physicians of London 1997, 31, 184-7.
Mansfield J, Charnley R. Practice in endoscopic cholangiopancreatography in Denmark differs from that in Britain. British Medical Journal 1996, 313(7067), 1263-1264.
McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. European Journal of Immunology 1996, 26, 2113-8.
Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn’s disease. Gut 1995, 36, 60-6.
Mansfield JC, Giaffer MH, Tindale WB, Holdsworth CD. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Gut 1995, 37, 679-83.
Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994, 106, 637-42.
Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier J-B, Jung J, Mondal K, Parkes M, Mathew CG, Fiedler K, McCarthy DJ, Sullivan PB, Rodrigues A, Travis SPL, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Russell RK, Wilson DC, Kelsen JR, Cornall R, Denson LA, Kugathasan S, Knaus UG, Serra EG, Anderson CA, Duerr RH, McGovern DPB, Cho J, Powrie F, Li VSW, Muise AM, Uhlig HH, Donnelly P, Bell J, Bentley D, McVean G, Ratcliffe P, Taylor J, Wilkie AOM, Donnelly P, Broxholme J, Buck D, Cazier J-B, Cornall R, Gregory L, Gregory J, Lunter G, McVean G, Taylor J, Tomlinson I, Wilkie AOM, Buck D, Allan C, Attar M, Green A, Gregory L, Humphray S, Kingsbury Z, Lamble S, Lonie L, Pagnamenta A, Piazza P, Polanco G, Trebes A, McVean G, Donnelly P, Cazier J-B, Broxholme J, Copley R, Fiddy S, Grocock R, Hatton E, Holmes C, Hughes L, Humburg P, Kanapin A, Lise S, Lunter G, Martin H, Murray L, McCarthy D, Rimmer A, Sahgal N, Wright B, Yau C, Arancibia C, Bailey A, Barnes E, Bird-Lieberman B, Brain O, Braden B, Collier J, East J, Geremia A, Howarth L, Keshav S, Klenerman P, Leedham S, Palmer R, Powrie F, Rodrigues A, Simmons A, Sullivan PB, Travis SPL, Uhlig HH, Heuschkel R, Zilbauer M, Auth MKH, Shah N, Kammermeier J, Croft N, Barakat F, Russell RK, Wilson DC, Henderson P, Braegger CP, Posovszky C, Fyderek K, Wedrychowicz A, Zurek M, Strisciuglio C, Elawad M, Lo B, Parkes M, Satsangi J, Anderson CA, Jostins L, Kennedy NA, Lamb CA, Ahmad T, Edwards C, Hart A, Hawkey C, Mansfield JC, Mowat C, Newman WG, Satsangi J, Simmons A, Tremelling M, Uhlig HH, Wilson DC, Lee JC, Prescott NJ, Lees CW, Mathew CG, Parkes M, Barrett JC, Anderson CA. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunology 2018, 11(2), 562-574.
Chew TS, Mansfield JC. Can faecal calprotectin predict relapse in inflammatory bowel disease: A mini review. Frontline Gastroenterology 2018, 9(1), 23-28.
Onoufriadis A, Stone K, Katsiamides A, Amar A, Omar Y, de Lange KM, Taylor K, Barrett JC, Pollok R, Hayee B, Mansfield JC, Sanderson JD, Simpson MA, Mathew CG, Prescott NJ. Exome sequencing and genotyping identify a rare variant in NLRP7 gene associated with ulcerative colitis. Journal of Crohn's and Colitis 2018, 12(3), 321-326.
Momozawa Y, Dmitrieva J, Theatre E, Deffontaine V, Rahmouni S, Charloteaux B, Crins F, Docampo E, Elansary M, Gori A-S, Lecut C, Mariman R, Mni M, Oury C, Altukhov I, Alexeev D, Aulchenko Y, Amininejad L, Bouma G, Hoentjen F, Lowenberg M, Oldenburg B, Pierik MJ, Vander Meulen-De Jong AE, Van Der Woude CJ, Visschedijk MC, Lathrop M, Hugot J-P, Weersma RK, De Vos M, Franchimont D, Vermeire S, Kubo M, Louis E, Georges M, Abraham C, Achkar J-P, Ahmad T, Ananthakrishnan AN, Andersen V, Anderson CA, Andrews JM, Annese V, Aumais G, Baidoo L, Baldassano RN, Bampton PA, Barclay M, Barrett JC, Bayless TM, Bethge J, Bitton A, Boucher G, Brand S, Brandt B, Brant SR, Buning C, Chew A, Cho JH, Cleynen I, Cohain A, Croft A, Daly MJ, D'Amato M, Danese S, De Jong D, Denapiene G, Denson LA, Devaney KL, Dewit O, D'Inca R, Dubinsky M, Duerr RH, Edwards C, Ellinghaus D, Essers J, Ferguson LR, Festen EA, Fleshner P, Florin T, Franke A, Fransen K, Gearry R, Gieger C, Glas J, Goyette P, Green T, Griffiths AM, Guthery SL, Hakonarson H, Halfvarson J, Hanigan K, Haritunians T, Hart A, Hawkey C, Hayward NK, Hedl M, Henderson P, Hu X, Huang H, Hui KY, Imielinski M, Ippoliti A, Jonaitis L, Jostins L, Karlsen TH, Kennedy NA, Khan MA, Kiudelis G, Krishnaprasad K, Kugathasan S, Kupcinskas L, Latiano A, Laukens D, Lawrance IC, Lee JC, Lees CW, Leja M, Van Limbergen J, Lionetti P, Liu JZ, Mahy G, Mansfield J, Massey D, Mathew CG, McGovern DPB, Milgrom R, Mitrovic M, Montgomery GW, Mowat C, Newman W, Ng A, Ng SC, Ng SME, Nikolaus S, Ning K, Nothen M, Oikonomou I, Palmieri O, Parkes M, Phillips A, Ponsioen CY, Potocnik U, Prescott NJ, Proctor DD, Radford-Smith G, Rahier J-F, Raychaudhuri S, Regueiro M, Rieder F, Rioux JD, Ripke S, Roberts R, Russell RK, Sanderson JD, Sans M, Satsangi J, Schadt EE, Schreiber S, Schulte D, Schumm LP, Scott R, Seielstad M, Sharma Y, Silverberg MS, Simms LA, Skieceviciene J, Spain SL, Steinhart AH, Stempak JM, Stronati L, Sventoraityte J, Targan SR, Taylor KM, Ter Velde A, Torkvist L, Tremelling M, Van Sommeren S, Vasiliauskas E, Verspaget HW, Walters T, Wang K, Wang M-H, Wei Z, Whiteman D, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zhang B, Zhang CK, Zhang H, Zhang W, Zhao H, Zhao ZZ. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nature Communications 2018, 9(1), 2427.
Lamb CA, Mansfield JC, Tew GW, Gibbons D, Long AK, Irving P, Diehl L, Eastham-Anderson J, Price MB, O'Boyle G, Jones DEJ, O'Byrne S, Hayday A, Keir ME, Egen JG, Kirby JA. aEß7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis. Journal of Crohn's and Colitis 2017, 11(5), 610-620.
Speight RA, Mansfield JC. Editorial: how effective is vedolizumab in the 'real world'?. Alimentary Pharmacology and Therapeutics 2017, 46(5), 555-556.
Lee JC, Biasci D, Roberts R, Gearry RB, Mansfield JC, Ahmad T, Prescotts NJ, Satsangi J, Wilson DC, Jostins L, Anderson CA, UK IBD Genetics Consortium, Traherne JA, Lyons PA, Parkes M, Smith KGC. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nature Genetics 2017, 49(2), 262-268.
de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, Jostins L, Rice DL, Gutierrez-Achuryl J, Ji SG, Heap G, Nimmo ER, Edwards C, Henderson P, Mowat C, Sanderson J, Satsangi J, Simmons A, Wilson DC, Tremelling M, Hart A, Mathew CG, Newman WG, Parkes M, Lees CW, Uhlig H, Hawkey C, Prescott NJ, Ahmad T, Mansfield JC, Anderson CA, Barrett JC. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nature Genetics 2017, 49(2), 256-261.
Luo Y, de Lange KM, Jostins L, Moutsianas L, Randall J, Kennedy NA, Lamb CA, McCarthy S, Ahmad T, Edwards C, Serra EG, Hart A, Hawkey C, Mansfield JC, Mowat C, Newman WG, Nichols S, Pollard M, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson DC, Lee JC, Prescott NJ, Lees CW, Mathew CG, Parkes M, Barrett JC, Anderson CA. Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7. Nature Genetics 2017, 49(2), 186-192.
Bodea CA, Neale BM, Ripke S, Barclay M, Peyrin-Biroulet L, Chamaillard M, Colombel J-F, Cottone M, Croft A, D'Inca R, Halfvarson J, Hanigan K, Henderson P, Hugot J-P, Karban A, Kennedy NA, Khan MA, Lemann M, Levine A, Massey D, Milla M, Montgomery GW, Ng SME, Oikonomou I, Peeters H, Proctor DD, Rahier J-F, Roberts R, Rutgeerts P, Seibold F, Stronati L, Taylor KM, Torkvist L, Ublick K, Van Limbergen J, Van Gossum A, Vatn MH, Zhang H, Zhang W, Andrews JM, Bampton PA, Florin TH, Gearry R, Krishnaprasad K, Lawrance IC, Mahy G, Radford-Smith G, Roberts RL, Simms LA, Amininijad L, Cleynen I, Dewit O, Franchimont D, Georges M, Laukens D, Theatre E, Vermeire S, Aumais G, Baidoo L, Barrie AM, Beck K, Bernard E-J, Binion DG, Bitton A, Brant SR, Cho JH, Cohen A, Croitoru K, Datta LW, Deslandres C, Duerr RH, Dutridge D, Ferguson J, Fultz J, Goyette P, Greenberg GR, Haritunians T, Jobin G, Katz S, Lahaie RG, McGovern DP, Nelson L, Ng SM, Ning K, Pare P, Regueiro MD, Rioux JD, Ruggiero E, Schumm LP, Schwartz M, Scott R, Sharma Y, Silverberg MS, Spears D, Steinhart AH, Stempak JM, Swoger JM, Tsagarelis C, Zhang C, Zhao H, Aerts J, Ahmad T, Arbury H, Attwood A, Auton A, Ball SG, Balmforth AJ, Barnes C, Barrett JC, Barroso I, Barton A, Bennett AJ, Bhaskar S, Blaszczyk K, Bowes J, Brand OJ, Braund PS, Bredin F, Breen G, Brown MJ, Bruce IN, Bull J, Burren OS, Burton J, Byrnes J, Caesar S, Cardin N, Clee CM, Coffey AJ, Connell JMC, Conrad DF, Cooper JD, Dominiczak AF, Downes K, Drummond HE, Dudakia D, Dunham A, Ebbs B, Eccles D, Edkins S, Edwards C, Elliot A, Emery P, Evans DM, Evans G, Eyre S, Farmer A, Ferrier N, Flynn E, Forbes A, Forty L, Franklyn JA, Frayling TM, Freathy RM, Giannoulatou E, Gibbs P, Gilbert P, Gordon-Smith K, Gray E, Green E, Groves CJ, Grozeva D, Gwilliam R, Hall A, Hammond N, Hardy M, Harrison P, Hassanali N, Hebaishi H, Hines S, Hinks A, Hitman GA, Hocking L, Holmes C, Howard E, Howard P, Howson JMM, Hughes D, Hunt S, Isaacs JD, Jain M, Jewell DP, Johnson T, Jolley JD, Jones IR, Jones LA, Kirov G, Langford CF, Lango-Allen H, Lathrop GM, Lee J, Lee KL, Lees C, Lewis K, Lindgren CM, Maisuria-Armer M, Maller J, Mansfield J, Marchini JL, Martin P, Massey DCO, McArdle WL, McGuffin P, McLay KE, McVean G, Mentzer A, Mimmack ML, Morgan AE, Morris AP, Mowat C, Munroe PB, Myers S, Newman W, Nimmo ER, O'Donovan MC, Onipinla A, Ovington NR, Owen MJ, Palin K, Palotie A, Parnell K, Pearson R, Pernet D, Perry JRB, Phillips A, Plagnol V, Prescott NJ, Prokopenko I, Quail MA, Rafelt S, Rayner NW, Reid DM, Renwick A, Ring SM, Robertson N, Robson S, Russell E, St Clair D, Sambrook JG, Sanderson JD, Sawcer SJ, Schuilenburg H, Scott CE, Scott R, Seal S, Shaw-Hawkins S, Shields BM, Simmonds MJ, Smyth DJ, Somaskantharajah E, Spanova K, Steer S, Stephens J, Stevens HE, Stirrups K, Stone MA, Strachan DP, Su Z, Symmons DPM, Thompson JR, Thomson W, Tobin MD, Travers ME, Turnbull C, Vukcevic D, Wain LV, Walker M, Walker NM, Wallace C, Warren-Perry M, Watkins NA, Webster J, Weedon MN, Wilson AG, Woodburn M, Wordsworth BP, Yau C, Young AH, Zeggini E, Brown MA, Burton PR, Caulfield MJ, Compston A, Farrall M, Gough SCL, Hall AS, Hattersley AT, Hill AVS, Mathew CG, Pembrey M, Satsangi J, Stratton MR, Worthington J, Hurles ME, Duncanson A, Ouwehand WH, Parkes M, Rahman N, Todd JA, Samani NJ, Kwiatkowski DP, McCarthy MI, Craddock N, Deloukas P, Donnelly P, Blackwell JM, Bramon E, Casas JP, Corvin A, Jankowski J, Markus HS, Palmer CNA, Plomin R, Rautanen A, Trembath RC, Viswanathan AC, Wood NW, Spencer CCA, Band G, Bellenguez C, Freeman C, Hellenthal G, Pirinen M, Strange A, Blackburn H, Bumpstead SJ, Dronov S, Gillman M, Jayakumar A, McCann OT, Liddle J, Potter SC, Ravindrarajah R, Ricketts M, Waller M, Weston P, Widaa S, Whittaker P, Daly MJ, Devlin B, Roeder K. A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control Studies. American Journal of Human Genetics 2016, 98(5), 857-868.
Rivas MA, Graham D, Sulem P, Stevens C, Desch AN, Goyette P, Gudbjartsson D, Jonsdottir I, Thorsteinsdottir U, Degenhardt F, Mucha S, Kurki MI, Li D, D'Amato M, Annese V, Vermeire S, Weersma RK, Halfvarson J, Paavola-Sakki P, Lappalainen M, Lek M, Cummings B, Tukiainen T, Haritunians T, Halme L, Koskinen LLE, Ananthakrishnan AN, Luo Y, Heap GA, Visschedijk MC, MacArthur DG, Neale BM, Ahmad T, Anderson CA, Brant SR, Duerr RH, Silverberg MS, Cho JH, Palotie A, Saavalainen P, Kontula K, Farkkila M, McGovern DPB, Franke A, Stefansson K, Rioux JD, Xavier RJ, Daly MJ, Barrett J, De Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar JP, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen JV, Milgrom R, Proctor D, Regueiro M, Schumm PL, Sharma Y, Stempak JM, Targan SR, Wang MH. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nature Communications 2016, 7, 12342.
Tew GW, Hackney JA, Gibbons D, Lamb CA, Luca D, Egen JG, Diehl L, Anderson JE, Vermeire S, Mansfield JC, Feagan BG, Panes J, Baumgart DC, Schreiber S, Dotan I, Sandborn WJ, Kirby JA, Irving PM, De Hertogh G, Van Assche GA, Rutgeerts P, O'Byrne S, Hayday A, Keir ME. Association Between Response to Etrolizumab and Expression of Integrin alpha E and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis. Gastroenterology 2016, 150(2), 477-487.e9.
Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrence I, Lees CW, Lewis S, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2016, 10(2), 149-158.
Mentzer A, Nayee S, Omar Y, Hullah E, Taylor K, Goel R, Bye H, Shembesh T, Elliott TR, Campbell H, Patel P, Nolan A, Mansfield J, Challacombe S, Escudier M, Mathew CG, Sanderson JD, Prescott NJ. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis. Inflammatory Bowel Diseases 2016, 22(7), 1552-1558.
Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D, Gordon JN, Hawthorne AB, Hilton M, Hutchings HA, Jawhari AU, Longo M, Mansfield J, Morgan JM, Rapport F, Seagrove AC, Sebastian S, Shaw I, Travis SPL, Watkins A. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. The Lancet Gastroenterology and Hepatology 2016, 1(1), 15-24.
Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy NA, Kupcinskas L, Lawrance IC, Lee JC, Satsangi J, Schreiber S, Theatre E, Van Der Meulen-De Jong AE, Weersma RK, Wilson DC, Parkes M, Vermeire S, Rioux JD, Mansfield J, Silverberg MS, Radford-Smith G, McGovern DPB, Barrett JC, Lees CW. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A genetic association study. The Lancet 2016, 387(10014), 156-167.
Speight RA, Davey T, White K, Kirby JA, Mansfield JC. Activation of the bile acid receptor, farnesoid-x receptor, maintains gut epithelial cell morphology, possibly via inhibition of myosin light chain kinase expression. In: 2nd Digestive Disorders Federation Conference 2015. 2015, London, UK: BMJ Group.
Speight RA, Whitehead A, Patman G, Mansfield JC, Reeves H, Kirby JA. Activation of the bile acid receptor, Farnesoid-X Receptor, may reduce Ileal Inflammatory Cytokine expression in an animal model of diet-induced obesity. In: 2nd Digestive Disorders Federation Conference 2015. 2015, London, UK: BMJ Group.
Ichikawa R, Eastham-Anderson J, Scherl A, Tew GW, Egen JG, Lamb CA, Mansfield JC, Kirby JA, Faubion WA, O'Byrne S, Keir ME. AlphaE (alpha E) integrin protein and gene expression are augmented in the ileum relative to the colon in Crohn's disease. In: 10th Congress of ECCO (European Crohn’s and Colitis Organisation). 2015, Barcelona: Oxford University Pres.
Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S, Daly MJ, Van Steen K, Duerr RH, Barrett JC, McGovern DPB, Schumm LP, Traherne JA, Carrington MN, Kosmoliaptsis V, Karlsen TH, Franke A, Rioux JD, Abraham C, Achkar J-P, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Anderson CA, Andrews JM, Aumais G, Baidoo L, Baldassano RN, Balschun T, Bampton PA, Barclay M, Bayless TM, Bethge J, Bis JC, Bitton A, Brand S, Brant SR, Buning C, Chew A, Cho JH, Cleynen I, Cohain A, Croft A, D'Amato M, Danese S, De Jong D, De Vos M, Denapiene G, Denson LA, Devaney KL, Dewit O, D'Inca R, Dubinsky M, Edwards C, Ellinghaus D, Essers J, Ferguson LR, Festen EA, Fleshner P, Florin T, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Green T, Griffiths AM, Guthery SL, Hakonarson H, Halfvarson J, Hanigan K, Haritunians T, Hart A, Hawkey C, Hayward NK, Hedl M, Henderson P, Hu X, Hui KY, Imielinski M, Ippoliti A, Jonaitis L, Kennedy NA, Khan MA, Kiudelis G, Kugathasan S, Kupcinskas L, Latiano A, Laukens D, Lawrance IC, Lee JC, Lees CW, Leja M, Van Limbergen J, Lionetti P, Liu JZ, Louis E, Mahy G, Mansfield J, Massey D, Mathew CG, Milgrom R, Mitrovic M, Montgomery G, Mowat C, Newman W, Ng A, Ng SC, Evelyn Ng SM, Nikolaus S, Ning K, Nothen M, Oikonomou I, Palmieri O, Parkes M, Phillips A, Ponsioen CY, Potocnik U, Prescott NJ, Proctor DD, Radford-Smith G, Rahier J-F, Raychaudhur S, Regueiro M, Rieder F, Roberts R, Russell RK, Sanderson JD, Sans M, Satsangi J, Schadt EE, Schreiber S, Schumm LP, Scott R, Seielstad M, Sharma Y, Silverberg MS, Simms LA, Skieceviciene J, Spain SL, Steinhart AH, Stempak JM, Stronati L, Sventoraityte J, Targan SR, Taylor KM, Ter Velde A, Theatre E, Torkvist L, Tremelling M, Van Der Meulen A, Van Sommeren S, Vasiliauskas E, Vermeire S, Verspaget HW, Walters T, Wwang K, Wwang M-H, Wweersma RK, Wei Z, Whiteman D, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhang H, Zhang W, Zhao H, Zhao ZZ. High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nature Genetics 2015, 47(2), 172-179.
Prescott NJ, Lehne B, Stone K, Lee JC, Taylor K, Knight J, Papouli E, Mirza MM, Simpson MA, Spain SL, Lu G, Fraternali F, Bumpstead SJ, Gray E, Amar A, Bye H, Green P, Chung-Faye G, Hayee B, Pollok R, Satsangi J, Parkes M, Barrett JC, Mansfield JC, Sanderson J, Lewis CM, Weale ME, Schlitt T, Mathew CG, UK IBD Genetics Consortium. Pooled Sequencing of 531 Genes in Inflammatory Bowel Disease Identifies an Associated Rare Variant in BTNL2 and Implicates Other Immune Related Genes. PLoS Genetics 2015, 11(4), e1005172.
Parker C, Lamb CA, Robinson M, Mansfield JC, Gunn M. Predicting inflammatory pathology at capsule enteroscopy: what is the utility of a raised faecal calprotectin?. In: 2nd Digestive Disorders Federation Conference 2015. 2015, London, UK: BMJ Group.
Heap GA, Weedon MN, Bewshea CM, Singh A, Chen M, Satchwel JB, Vivian JP, So K, Dubois PC, Andrews JM, Annese V, Bampton P, Barnardo M, Bell S, Cole A, Connor SJ, Creed T, Cummings FR, D'Amato M, Daneshmend TK, Fedorak RN, Florin TH, Gaya DR, Greig E, Halfvarson J, Hart A, Irving PM, Jones G, Karban A, Lawrance IC, Lee JC, Lees C, Lev-Tzion R, Lindsay J, Mansfield J, Mawdsley J, Mazhar Z, Parkes M, Parnell K, Orchard TR, Radford-Smith G, Russell RK, Reffitt D, Satsangi J, Silverberg MS, Sturniolo GC, Tremelling M, Tsianos EV, van Heel DA, Walsh A, Watermeyer G, Weersma RK, Zeissig S, Rossjohn J, Holden AL, Ahmad T, Int Serious Adverse Events Consort, IBD Pharmacogenetics Study Grp. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics 2014, 46(10), 1131-1134.
Vermeire S, O'Byrne S, Keir M, Williams M, Lu TT, Mansfield JC, Lamb CA, Feagan BG, Panes J, Salas A, Baumgart DC, Schreiber S, Dotan I, Sandborn WJ, Tew GW, Luca D, Tang MT, Diehl L, Eastham-Anderson J, De Hertogh G, Perrier C, Egen JG, Kirby JA, van Assche G, Rutgeerts P. Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial. Lancet 2014, 384(9940), 309-318.
Perowne R, Lamb C, Speight RA, Price M, Mansfield J. Faecal Calprotectin Is Useful In Predicting Long Term Disease Recurrence In Post-operative Crohn’s. In: British Society of Gastroenterology Annual General Meeting. 2014, Manchester: BMJ Group.
Kennedy NA, Kalla R, Warner B, Gambles CJ, Musy R, Reynolds S, Dattani R, Nayee H, Felwick R, Harris R, Marriott S, Senanayake SM, Lamb CA, Al-Hilou H, Gaya DR, Irving PM, Mansfield J, Parkes M, Ahmad T, Cummings JRF, Arnott ID, Satsangi J, Lobo AJ, Smith M, Lindsay JO, Lees CW. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Alimentary Pharmacology & Therapeutics 2014, 40(11-12), 1313-1323.
Lamb CA, Mansfield JC, Tew GW, Gibbons DL, Long AK, Irving PM, Diehl L, Eastham-Anderson J, O'Boyle G, Jones DEJ, Hayday AC, Keir ME, Egen JG, Kirby JA. Ulcerative colitis: The alpha E beta 7 integrin is associated with a high frequency of Th17, Th1 and Th17/Th1 CD4 lymphocytes. In: European Crohn's and Colitis Organisation (ECCO) Congress. 2014, Copenhagen: Oxford University Press.
Lamb CA, Mansfield JC, Tew GW, Gibbons D, Long AK, Irving PM, Deihl L, Anderson JE, O'Boyle G, Jones DE, Hayday A, Keir M, Egen JG, Kirby JA. Ulcerative Colitis: The Alpha-e-beta-7 Integrin Is Associated With A High Frequency Of Th17, Th1 And Th17/th1 Cd4 Lymphocytes. In: British Society of Gastroenterology Annual General Meeting. 2014, Manchester: BMJ Group.
Mitchell L, Hussey J, Mansfield J, Gunn M, McLelland J, Needham S. Vulval oedema: how many doctors does it take to make a diagnosis?. European Journal of Obstetrics & Gynecology and Reproductive Biology 2014, 172, 137-138.
Rutgeerts PJ, Fedorak RN, Hommes DW, Sturm A, Baumgart DC, Bressler B, Schreiber S, Mansfield JC, Williams M, Tang M, Visich J, Wei XH, Keir M, Luca D, Danilenko D, Egen J, O'Byrne S. A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis. Gut 2013, 62(8), 1122-1130.
Lamb CA, Lamb EIM, Mansfield JC, Sankar KN. Sexually transmitted infections manifesting as proctitis. Frontline Gastroenterology 2013, 4(1), 32-40.
Lamb CA, O'Boyle G, Jones DE, Mansfield JC, Kirby JA. Blockade of the B7 integrin prevents adherence of t lymphocytes to MAdCAM-1 in an in vitro model of vascular microcirculation post-capillary shear flow. In: Digestive Disorders Federation Meeting. 2012, Liverpool, UK: BMJ Group.
Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu XL, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao HY, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH, Int IBD Genetics Consortium IIBDGC. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491(7422), 119-124.
Maggina P, Stroud C, Bourne H, Cole T, Collin M, Jackson G, Flood T, Barge D, Mansfield J, Hodges S, Spickett G, Gennery A. Idiopathic colitis following haematopoietic stem cell transplantation for chronic granulomatous disease: Three cases at a national centre. In: 15th Biennial Meeting European Society for Immunodeficiency (ESID). 2012, Florence, Italy: Springer.
Lamb CA, Mansfield JC. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease. Frontline Gastroenterology 2011, 2, 13-18.
Craggs A, Donaldson P, Welfare M, Thompson NP, Mansfield JC. Genetic association studies in IBD; Negative results from three candidate genes. In: British Society of Gastroenterology Annual Meeting. 2001, Glasgow, UK: BMJ Group.
Nylander D, Bramble MG, Cunliffe WJ, Mansfield JC. Recurrent Crohn's disease after surgery is dependent on timing of surgery and smoking, but not on use of 5ASA drugs. In: Gut. 1999, BMJ Group.